$EDIT slices into a 22% gain in Segment 6 as this gene editing pioneer cuts through the noise with a massive breakout move!
Editas Medicine, a genome editing company delivers a powerful 22% gain in five trading days. After turning back into Segments 3-5 (yellow) after selection for two days $EDIT then hops back into Segment 6 and skyrockets!
🚀 Surging from $2.18 to $2.66 after its MDA Breakout selection on March 4th, wrapping up on March 11th a clean $0.48 per share gain for this cutting-edge biotech!
Don't miss the next gene editing breakout — or the next big move in any sector! Build your watchlist with Segment 6 picks across biotech, tech, and beyond. Start your free trial to V&M Breakouts today and catch the signals before they move!
$ULCC takes flight in Segment 6 gaining 18% as this ultra-low-cost carrier climbs higher!
$AMC lights up the screen in Segment 6 gaining 27% as momentum surges into the summer!
Are you getting daily breakout picks? | $CLOV powers up in Segment 6 gaining 15%
The Top Blog posts highlights from last week's MDA Breakout Stock Picks, published twice-daily on the V&M Breakouts Dashboard. Subscribe for a 14-day Free Trial to get today's picks or sign up to get free email updates.